Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @CPathInstitute
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @CPathInstitute
-
C-Path’s ePRO Consortium is co-sponsoring the
@DrugInfoAssn 2020 Digital Technology in Clinical Trials Conference, March 30-31 in Boston. Register now for early bird rates: https://bit.ly/2Z4yZ2y#CPath#ePRO#eCOA#DIA#COA#electronicpatientreportedoutcomes#clinicaltrialspic.twitter.com/R3K0D7oQVi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
C-Path's
#Duchenne Regulatory Science#Consortium met w/the@EMA_News SAWP on the qualification procedure for a Duchenne#clinicaltrial simulator. Proud to be accelerating#drug development in DMD for patients around the globe. https://bit.ly/30GV8Fb#CPath#collaborationpic.twitter.com/sFyLAVF1uE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
C-Path’s ePRO Consortium is pleased to co-sponsor the
@DrugInfoAssn 2020 Digital Technology in Clinical Trials Conference, March 30-31 in Boston. Register now: https://bit.ly/2Z4yZ2y#CPath#ePRO#eCOA#DIA#COA#PRO#electronicpatientreportedoutcomes#clinicaltrialspic.twitter.com/yVT3zo35Em
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great
#careeropportunity for a Sr. Project Manager w/#CPath's Critical Path for#Alzheimers Disease#CPAD#consortium. Apply now if working to advance#drugdevelopment tools in#AD excites you! https://bit.ly/2EpDvPG#globalhealth#projectmanager@susivakpic.twitter.com/V0WdxgnGMV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
#CPath team honored Dr.@RayWoosley and Dr. Martha Brumfield Friday announcing that the main boardrooms at#Tucson headquarters will be renamed after them in honor of their lasting and significant contributions to C-Path. Congrats!#globalhealth#drugdevelopment#datasharingpic.twitter.com/G71w9URuBi
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
C-Path’s John-Michael Sauer was honored to be a panel member at today’s
@dukemargolis public meeting addressing drug safety and efficacy for liver diseases. More: https://bit.ly/2P3Ou7q#CPath#NASHinnovation#liverdisease#globalhealth#collaboration#drugsafety#dukemargolispic.twitter.com/wQiYkSW5Vt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New
#workshop summary available from C-Path,@dukemargolis and@US_FDA, Advancing the Development and Implementation of Analysis Data Standards: Key Challenges and Opportunities. https://bit.ly/2YjoTue#CPath#globalhealth#collaboration#FDA#datastandards#drugdevelopmentHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Join C-Path panelists for
@US_FDA public#workshop, Patient-Focused Drug Development: Incorporating Clinical Outcome Assessments into Endpoints for Regulatory Decision Making, Dec. 6. Attend online: https://bit.ly/2PeGWO7#CPath#collaboration#drugdevelopment#parkinsonspic.twitter.com/0w1XStuzbQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Grateful today and every day for our collaborators and staff who help us accelerate the path to a healthier world.
#CPath#HappyThanksgiving#globalhealth#collaborationpic.twitter.com/CHE53eBHAP
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
C-Path staff to discuss
#liverdisease pathophysiology and the impact of liver dysfunction on pharmacokinetics, pharmacodynamics, Dec. 9 public meeting sponsored by@dukemargolis. Register: https://bit.ly/2QZkU4F#CPath#NASH#globalhealth#collaboration#drugsafetypic.twitter.com/Hr1FcSiPuo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
C-Path’s T1D Consortium is progressing a quantitative modeling approach to optimize trial designs in T1D: https://bit.ly/2KSgI2E .
#CPath#T1D#datasharing#drugdevelopment#quantitativemedicine#DiabetesAwarenessMonthHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
C-Path, in collaboration with
@CrohnsColitisFn and@FNIH_org, is convening the 2019#IBDBiomarkerSummit this week. Learn more about our collaborative efforts to accelerate cures for IBD and peek at the agenda here: https://bit.ly/344F1Sv .#CPath#drugdevelopment#IBD#biomakerspic.twitter.com/SFDZBNm2Zl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In honor of
#WorldDiabetesDay, C-Path is highlighting the work its Type 1 Diabetes#Consortium is doing in collaboration with@JDRF and the@EMA_News in autoantibodies as a way to prevent#T1D. https://bit.ly/2CFGZNf#CPath#diabetesawareness#datasharing#drugdevelopment#EMApic.twitter.com/QFgTLmAPbb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RDCA-DAP, developed by C-Path and
@RareDiseases, provides new tools and methodologies to improve#clinicaltrial design and empower the#raredisease community. Access video + event presentations from the launch: https://bit.ly/34ZMDpy#CPath#FDA#NORD#rdcadap#rarecurespic.twitter.com/meQ6QO7G1y
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you
@PKDFoundation for hosting C-Path’s Polycystic Kidney Disease Outcomes Consortium. PKDOC is committed to developing tools and processes that lead to development and regulatory approval of new treatments in#PKD. https://bit.ly/33wPC8G#CPath#kidneyweek2019pic.twitter.com/dT8oR2NGRf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
C-Path’s Electronic Patient-Reported Outcome (ePRO)
#Consortium had a great meeting in Copenhagen at#ISPOREurope this week. More: https://bit.ly/2PUciLR#CPath#patientreportedoutcome#drugdevelopment#globalhealth#clinicaltrials#regulatoryscience#datasharing#collaborationpic.twitter.com/9iqYhzD8We
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Through support from the
@mssociety, C-Path’s Multiple Sclerosis Outcome Assessment Consortium validated four clinical measurement tools that detect changes in walking, vision, cognition and manual dexterity. Access: https://bit.ly/33kPMzR#CPath#drugdevelopment#MSHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
C-Path proslijedio/la je Tweet
#TBT: last year our Biomarkers Consortium &@CPathInstitute accomplished the 1st ever qualification of a clinical safety#biomarker awarded by the@US_FDA as a result of the FNIH Kidney Safety Project. http://ow.ly/gQLi50wVvAZ pic.twitter.com/WJKAWuRMeN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.